H-1PV treated patients displayed an increase in tumor-infiltrating cytotoxic T cells, induction of cathepsin B, and the expression of IFN-γ and IL-2, among other cytokines within the tumor microenvironment (Table 3). The gene discussed is CTSB; the disease is neoplasm.